Latvia - Antiarrhythmic Medicine Use
Since 2014, Latvia Antiarrhythmic Medicine Use jumped by 3% year on year. With 2.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 15 among other countries in Antiarrhythmic Medicine Use. Slovakia topped the ranking with 10.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 3.9% compared to 2018. Czech Republic, Belgium and Italy respectively ranked number 2, 3 and 4 in this ranking. South Korea witnessed the best average annual growth at +7% per year, while Chile was the worst growing country at -4.1% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 2.90 |
2018 | 2.70 |
2017 | 2.70 |
2016 | 2.60 |
2015 | 2.60 |
Download all data from 2012 to 2019
How does Latvia rank in Antiarrhythmic Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Slovakia
|
11 | 2019 | +3.9 % | +1.4 % | View data | |
2 |
#2
Czech Republic
|
9 | 2019 | +2.3 % | +1.9 % | View data | |
15 |
#15
Germany
|
3 | 2019 | +0.0 % | -1.3 % | View data | |
15 |
#15
Latvia
|
3 | 2019 | +7.4 % | +3.0 % | View data | |
17 |
#17
Netherlands
|
3 | 2019 | +0.0 % | -2.2 % | View data |